StageZero Life Sciences Ltd.
SZLS
Classificação em ações
#36000
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Preço da ação
$0.02770208
Última sincronização: 2025-03-10
Valor de mercado
$2.92M
Variação (1 dia)
-0.46%
Variação (1 ano)
443.18%
País
CA
Negociar StageZero Life Sciences Ltd. (SZLS)
Categoria
Healthcare
Histórico de preços das ações de StageZero Life Sciences Ltd. (SZLS)
Preço de fecho mais alto: $0.00 em 2026-10-01
Preço de fecho mais baixo: $2.81 em 2009-09-01
Preço de fecho mais baixo: $2.81 em 2009-09-01
Histórico de preços das ações da StageZero Life Sciences Ltd. de 2009 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -73.56% |
| 2024 | -62.97% |
| 2023 | -33.87% |
| 2022 | -78.51% |
| 2021 | -55.53% |
| 2020 | 1,478.24% |
| 2019 | 52.97% |
| 2018 | -82.67% |
| 2017 | -60.46% |
| 2016 | 1,319.73% |
| 2015 | -98.57% |
| 2014 | 178.20% |
| 2013 | -10.96% |
| 2012 | -45.98% |
| 2011 | -18.68% |
| 2010 | -42.93% |
| 2009 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
